Global mRNA Vaccine Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: Qy Research

Pages: 93

Report ID: 31836

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

The global mRNA Vaccine market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on mRNA Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall mRNA Vaccine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine

Segment by Application
Infectious Disease
Cancer
Other

Table of Contents

Executive Summary
1 mRNA Vaccine Market Overview
1.1 Product Overview and Scope of mRNA Vaccine
1.2 mRNA Vaccine Segment by Type
1.2.1 Global mRNA Vaccine Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Standardization Of Cancer Treatment MRNA Vaccine
1.2.3 Individualized Cancer Treatment MRNA Vaccine
1.2.4 Infectious Disease Treatment MRNA Vaccine
1.2.5 Infection Prevention MRNA Vaccine
1.3 mRNA Vaccine Segment by Application
1.3.1 mRNA Vaccine Consumption Comparison by Application (2014-2025)
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Other
1.4 Global mRNA Vaccine Market by Region
1.4.1 Global mRNA Vaccine Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global mRNA Vaccine Market Size
1.5.1 Global mRNA Vaccine Revenue (2014-2025)
1.5.2 Global mRNA Vaccine Production (2014-2025)

2 Global mRNA Vaccine Market Competition by Manufacturers
2.1 Global mRNA Vaccine Production Market Share by Manufacturers (2014-2019)
2.2 Global mRNA Vaccine Revenue Share by Manufacturers (2014-2019)
2.3 Global mRNA Vaccine Average Price by Manufacturers (2014-2019)
2.4 Manufacturers mRNA Vaccine Production Sites, Area Served, Product Types
2.5 mRNA Vaccine Market Competitive Situation and Trends
2.5.1 mRNA Vaccine Market Concentration Rate
2.5.2 mRNA Vaccine Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global mRNA Vaccine Production Market Share by Regions
3.1 Global mRNA Vaccine Production Market Share by Regions
3.2 Global mRNA Vaccine Revenue Market Share by Regions (2014-2019)
3.3 Global mRNA Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America mRNA Vaccine Production
3.4.1 North America mRNA Vaccine Production Growth Rate (2014-2019)
3.4.2 North America mRNA Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe mRNA Vaccine Production
3.5.1 Europe mRNA Vaccine Production Growth Rate (2014-2019)
3.5.2 Europe mRNA Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China mRNA Vaccine Production (2014-2019)
3.6.1 China mRNA Vaccine Production Growth Rate (2014-2019)
3.6.2 China mRNA Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan mRNA Vaccine Production (2014-2019)
3.7.1 Japan mRNA Vaccine Production Growth Rate (2014-2019)
3.7.2 Japan mRNA Vaccine Production, Revenue, Price and Gross Margin (2014-2019)

4 Global mRNA Vaccine Consumption by Regions
4.1 Global mRNA Vaccine Consumption by Regions
4.2 North America mRNA Vaccine Consumption (2014-2019)
4.3 Europe mRNA Vaccine Consumption (2014-2019)
4.4 China mRNA Vaccine Consumption (2014-2019)
4.5 Japan mRNA Vaccine Consumption (2014-2019)

5 Global mRNA Vaccine Production, Revenue, Price Trend by Type
5.1 Global mRNA Vaccine Production Market Share by Type (2014-2019)
5.2 Global mRNA Vaccine Revenue Market Share by Type (2014-2019)
5.3 Global mRNA Vaccine Price by Type (2014-2019)
5.4 Global mRNA Vaccine Production Growth by Type (2014-2019)

6 Global mRNA Vaccine Market Analysis by Applications
6.1 Global mRNA Vaccine Consumption Market Share by Application (2014-2019)
6.2 Global mRNA Vaccine Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in mRNA Vaccine Business
7.1 Moderna Therapeutics
7.1.1 Moderna Therapeutics mRNA Vaccine Production Sites and Area Served
7.1.2 mRNA Vaccine Product Introduction, Application and Specification
7.1.3 Moderna Therapeutics mRNA Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 CureVac
7.2.1 CureVac mRNA Vaccine Production Sites and Area Served
7.2.2 mRNA Vaccine Product Introduction, Application and Specification
7.2.3 CureVac mRNA Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Translate Bio
7.3.1 Translate Bio mRNA Vaccine Production Sites and Area Served
7.3.2 mRNA Vaccine Product Introduction, Application and Specification
7.3.3 Translate Bio mRNA Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 BioNTech
7.4.1 BioNTech mRNA Vaccine Production Sites and Area Served
7.4.2 mRNA Vaccine Product Introduction, Application and Specification
7.4.3 BioNTech mRNA Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Sangamo Therapeutics
7.5.1 Sangamo Therapeutics mRNA Vaccine Production Sites and Area Served
7.5.2 mRNA Vaccine Product Introduction, Application and Specification
7.5.3 Sangamo Therapeutics mRNA Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Argos Therapeutics
7.6.1 Argos Therapeutics mRNA Vaccine Production Sites and Area Served
7.6.2 mRNA Vaccine Product Introduction, Application and Specification
7.6.3 Argos Therapeutics mRNA Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 In-Cell-Art
7.7.1 In-Cell-Art mRNA Vaccine Production Sites and Area Served
7.7.2 mRNA Vaccine Product Introduction, Application and Specification
7.7.3 In-Cell-Art mRNA Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 eTheRNA
7.8.1 eTheRNA mRNA Vaccine Production Sites and Area Served
7.8.2 mRNA Vaccine Product Introduction, Application and Specification
7.8.3 eTheRNA mRNA Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Ethris
7.9.1 Ethris mRNA Vaccine Production Sites and Area Served
7.9.2 mRNA Vaccine Product Introduction, Application and Specification
7.9.3 Ethris mRNA Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 Tiba Biotechnology
7.10.1 Tiba Biotechnology mRNA Vaccine Production Sites and Area Served
7.10.2 mRNA Vaccine Product Introduction, Application and Specification
7.10.3 Tiba Biotechnology mRNA Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served

8 mRNA Vaccine Manufacturing Cost Analysis
8.1 mRNA Vaccine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of mRNA Vaccine
8.4 mRNA Vaccine Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 mRNA Vaccine Distributors List
9.3 mRNA Vaccine Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global mRNA Vaccine Market Forecast
11.1 Global mRNA Vaccine Production, Revenue Forecast
11.1.1 Global mRNA Vaccine Production Growth Rate Forecast (2019-2025)
11.1.2 Global mRNA Vaccine Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global mRNA Vaccine Price and Trend Forecast (2019-2025)
11.2 Global mRNA Vaccine Production Forecast by Regions (2019-2025)
11.2.1 North America mRNA Vaccine Production, Revenue Forecast (2019-2025)
11.2.2 Europe mRNA Vaccine Production, Revenue Forecast (2019-2025)
11.2.3 China mRNA Vaccine Production, Revenue Forecast (2019-2025)
11.2.4 Japan mRNA Vaccine Production, Revenue Forecast (2019-2025)
11.3 Global mRNA Vaccine Consumption Forecast by Regions (2019-2025)
11.3.1 North America mRNA Vaccine Consumption Forecast (2019-2025)
11.3.2 Europe mRNA Vaccine Consumption Forecast (2019-2025)
11.3.3 China mRNA Vaccine Consumption Forecast (2019-2025)
11.3.4 Japan mRNA Vaccine Consumption Forecast (2019-2025)
11.4 Global mRNA Vaccine Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global mRNA Vaccine Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer